Regulation of bone formation is important in the pathogenesis of many conditions such as osteoporosis, fracture healing, and loosening of orthopedic implants. We have recently identified a novel rat cDNA (best5) by differential display PCR that is regulated during osteoblast differentiation and bone formation in vitro and in vivo. 
In healthy adults, the skeleton undergoes continuous turnover, bone remodeling, during which bone is resorbed and formed. The processes of resorption and formation are tightly coupled and orchestrated by osteoclasts and osteoblasts in order to maintain optimal bone mass. Osteoclasts are derived from hematopoietic precursors, which also give rise to monocytes and tissue macrophages. Osteoblasts, however, originate from stromal mesenchymal stem cells that can also give rise to fibroblasts, chondrocytes, adipocytes, and muscle cells. Disruption of the delicate balance between bone resorption and formation can occur due to changes in mechanical loading, hormonal and inflammatory cytokines, or growth factor levels. This disruption results in either increased or decreased bone mass (osteopetrosis and osteoporosis, respectively) and skeletal dysfunction. It is becoming increasingly evident that the interactions between the cells of bone, marrow, and the immune system are important during both normal bone maintenance and in disease conditions (1, 2) . Among the cytokines implicated in these interactions are the two distinct types of interferons (Type I: IFN-␣/␤, and Type II: IFN-␥). The IFNs are responsible for a wide range of cellular responses including regulation of cell growth, immunomodulation, resistance to infectious agents, cell metabolism, and differentiation (3) . Although Type I and Type II IFNs are structurally unrelated and operate via distinct receptors, they exhibit many common biological effects mediated by the JAK-STAT pathway (for reviews, see refs 4, 5) . The JAK-STAT intracellular pathway is also used by other cytokines, including those cytokines whose receptors belong to the Type I cytokine receptor superfamily. Although the exact role of the IFNs in bone is presently unclear, evidence for their involvement in skeletal tissue biology is growing (6) . Interferon-␣ is known to suppress the proliferation of osteoprogenitor cells (7, 8) and to modify the expression of a number of important cytokines in bone marrow cells (9, 10, 11) . Interferon-␥ inhibits bone resorption (12) (13) (14) and exhibits antiproliferative actions on bone-derived cells (15) (16) (17) . Overexpression of IFN-␥ in transgenic mice results in degenerative lesions in bone and cartilage as well as reduced numbers of B cells in bone marrow, spleen, and lymph nodes (18) . The specific mechanisms involved in inflammatory diseases that involve bone (such as osteoarthritis and rheumatoid arthritis, RA) are not clear. However, further insight into the molecular mechanisms of IFN action in these conditions could be of important clinical significance, since both the mRNA and protein for IFN-␣ (19) and IFN-␥ (20, 21) have been detected in RA synovial tissue. In addition, the ability of IFNs to modulate the proliferation of osteoprogenitor cells indicates an important role for these cytokines during normal and pathological bone remodeling.
The best5 (bone-expressed sequence tag 5) gene was originally identified as part of a differential display polymerase chain reaction (PCR) project identifying genes regulated by estrogen in whole bone samples. Here we report on the molecular characterization of this novel cDNA and show that it is expressed predominantly in bone and spleen. The temporal pattern of best5 expression in primary rat osteoblasts indicates that it may play an important role in osteoblast function or differentiation. We also show that the best5 gene is regulated by both IFN-␣ and IFN-␥ and that mechanical loading of bone in vivo, which induces proliferation and differentiation of osteoblasts, results in rapid induction of best5 protein expression. These data provide evidence that best5 induction is part of the process of osteoblast differentiation and bone formation, and increases links between cytokines of the immune system and physiological regulation of bone mass.
MATERIALS AND METHODS

Tissue samples and RNA purification
Tissue samples were obtained from 8-wk-old Wistar rats and snap frozen in liquid nitrogen. Cortical bone and marrow samples were obtained from the tibiae of the same animals by flushing out and collecting marrow cells using 1.0 ml of TRIzol reagent (Life Technologies, Inc.-BRL, Paisley, U.K.). Traces of muscle and periosteum were removed from the outside surfaces of the flushed cortical bone samples by scraping with a clean scalpel blade. Total RNA was purified by homogenization of frozen tissue samples (100 mg) in liquid nitrogen with 1.0 ml of TRIzol reagent using a MicroDismembrator (B. Braun Biotech International, Germany). Poly(A)-enriched mRNA was purified from whole rat tibiae (cortical bone plus marrow) total RNA using Oligotex mRNA Kit (Qiagen Ltd., Crawley, U.K.). Integrity of total and poly(A)-enriched RNA samples was assessed by agarose-formaldehyde gel electrophoresis.
Cloning of best5 cDNA
The best5 gene was initially identified as part of a differential display PCR (DD-PCR) project investigating the expression profile of genes in the tibiae of ovariectomized rats. The DD-PCR experiments were performed using the Delta RNA Fingerprinting kit (Clontech Laboratories U.K. Ltd., Basingstoke, U.K.) on DNase I-treated total RNA from whole rat tibiae. The original 576 bp best5 DD-PCR product was cloned into pCR-Script SK(ϩ) (Stratagene Ltd., Amsterdam, The Netherlands) and five individual clones were sequenced using an ABI 377 system (Perkin Elmer, Warrington, U.K.).
This sequence information was used to design gene-specific PCR primers for the cloning of the full-length best5 cDNA by the rapid amplification of cDNA ends (RACE) technique (best5 RACE1 primer: 5Ј-TGAGGCCTGCATGATTGTTCTTG-GACTACT-3Ј and best5 RACE2 primer: 5Ј-AGCTCGTGTTT-TACCCTTTTCATGGACTGA-3Ј). The RACE reactions were performed using the Marathon cDNA Amplification Kit (Clontech Ltd.). Briefly, double-stranded cDNA was synthesized from 1.5 g of poly(A)-enriched mRNA purified from pooled total RNA (400 g) obtained from whole rat tibiae. The best5 RACE reactions were performed, after adapter ligation, using a two-step touchdown PCR protocol (94°C for 1 min; 5 cycles of 94°C for 5 s, 72°C for 4 min; 5 cycles of 94°C for 5 s, 70°C for 4 min; 20 cycles of 94°C for 5 s, 68°C for 4 min). The resulting 5Ј and 3Ј RACE products were separated on a 1.2% agarose gel and the two major PCR products were excised from the gel, purified with GeneClean II Spin kit (BIO 101, La Jolla, Calif.), and cloned into the vector pCR 2.1 using the TA Cloning Kit (Invitrogen BV, Groningen, The Netherlands). Four individual clones for each of the RACE products were sequenced using internal sequencing primers, as required, to obtain data along the full length of the inserts from both DNA strands.
A set of gene specific PCR primers (best5-PCR1F: 5Ј-GGC-CACCGGTACAGTTCAAA-3Ј and best5-PCR1R: 5Ј-CAATG-GCAGCCTTATCCGGAGAG-3Ј) were designed to amplify a 450 bp region of the best5 cDNA, including part of the potential coding region. Total RNA (10 g) from whole rat tibiae were used for the synthesis of cDNA using the Firststrand cDNA Synthesis kit (Life Technologies, Inc.-BRL) with oligo-d(T) as the primer. The cDNA reaction was diluted 1:10 and 1 l used for PCR with the best5-PCR1F and best5-PCR1R primers (94°C for 1 min; 28 cycles of 94°C for 10 s, 58°C for 30 s, 72°C for 1 min; followed by a final extension of 72°C for 5 min). The resulting 450 bp best5-PCR1 product was cloned into the vector pCR 2.1 (Invitrogen BV) and five independent clones were sequenced using an ABI 377 (Perkin Elmer) to confirm the identity of the PCR inserts. The best5-PCR1 product was used as template for the generation of all subsequent probes for Northern blot analyses.
All PCR reactions were performed using a PTC-200 DNA Engine (GRI Ltd., Dunmow, U.K.) and Platinum Taq polymerase (Life Technologies, Inc.-BRL), except the RACE reactions, which were performed using Advantage Taq Polymerase mix (Clontech Ltd.).
Computer analysis of best5 cDNA
Sequence similarity database searches were performed using the gapped BLAST (BLAST2) program (22) (http://www. ncbi.nlm.nih.gov/BLAST) against nonredundant sequence database 'nr'. The significance of a match is assessed with an E value, which measures the expected number of sequences in the database that would achieve a given score by random. Protein domain search was performed using search machinery within the Protein Domain Database ProDom release 99.1 (http://protein.toulouse.inra.fr/prodom.html). This database has been constructed from a procedure based on recursive searches using PSI-BLAST (22, 23) .
Local sequence similarity between pairs of sequences was measured using the program BESTFIT within Wisconsin Package Version 9.1 (GCG, Madison, Wis.). Significance of the alignment was assessed with the Z score that counted the number of standard deviations from the mean score achieved after one of the sequences was randomized 100 times. Multiple sequence alignment was calculated using program CLUSTAL W (24) (http://www2.ebi.ac.uk/clustalw/).
Cell culture
Human osteosarcoma cell line MG63 and primary rat osteoblasts (ROBs) were maintained in DMEM supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (Life Technologies, Inc.-BRL).
Cultures of primary ROBs were obtained essentially as described previously (25) , with the following modifications. Calvaria from 3-day-old neonatal rats were sequentially digested with 1 mg/ml collagenase in HBSS (Sigma, Poole, U.K.) and EDTA (4 mM). Cells were seeded onto 75 cm 2 tissue culture flasks with DMEM plus 10% FCS. On gaining confluence, cells were split 1:3 (passage 1) in DMEM, 10% FCS. Primary cells at passage 2 (1:3 split) were plated onto 25 cm 2 flasks containing DMEM, 10% FCS and grown until reaching confluence (48 h). At this point (referred to as day 0) the media was replaced with fresh DMEM supplemented with 10% FCS, 10 nM dexamethasone, 5 mM ␤ glycerol phosphate, and 100 g/ml L-ascorbic acid phosphate. This osteo-inductive media promotes the differentiation/maturation of cells in the culture to the osteoblast phenotype. 
Northern blot analysis
Total RNA samples (10 g) were fractionated on 1% agarose gels containing 6.7% formaldehyde and transferred by capillary blotting onto Zeta-Probe GT membranes (Bio-Rad Laboratories Ltd., Hemel Hempstead, U.K.) in 10ϫ SSC. Probes for the Northern hybridizations were prepared using 120 ng of the 450 bp best5-PCR1 product as template in randomprimed reactions (HighPrime Radiolabeling Kit; Boehringer Mannheim Ltd.) containing 50 Ci of 32 P ␣-dCTP (3,000 Ci/mmol; Amersham Pharmacia Biotech, Little Chalfont, U.K.). Hybridizations were carried out at 68°C for 1 h in QuickHyb (Stratagene BV) and blots were washed three times for 10 min each in 2ϫ SSC, 0.1% sodium dodecyl sulfate (SDS) at room temperature, followed by two washes of 15 min each in 0.1ϫ SSC, 0.1% SDS at 60°C.
Antisera production and assessment
A peptide (BEST5-PEP-1: amino acid residues 344-RG-GKYVWSKADLKLDW-360 of the best5 coding region) was synthesized and used for the production of polyclonal antisera in rabbits (B1047 and B1062) after coupling to KLH carrier protein (Genosys Biotechnologies Ltd., Cambridge, U.K.). Rabbit bleeds were assessed for antibody production by ELISAs using 96-well plates coated with the uncoupled BEST5-PEP-1 peptide (100 ng/well) and incubated with doubling dilutions (1: 400 to 1:819,200) of antisera B1047 and B1062. Antisera B1062 was chosen for all subsequent use in immunoblot analyses and characterization studies.
Immunoblot analysis
Total cell lysates from primary ROBs and MG63 cells were obtained by washing cells with PBS, followed by the addition of lysis buffer (20 mM Tris HCl pH 7.5; 2 mM EDTA; 0.5 mM EGTA; 1 mM DTT; 2 mM PMSF; 10 g/ml aprotin; 0.3 M sucrose; 0.1% Triton X-100; 0.1% SDS). Cells were scraped off the surface of culture dishes in Lysis buffer and stored at Ϫ80°C. Total cell lysate samples were centrifuged at 13,000 rpm for 10 min at 4°C, and 15 l of the resulting supernatant was mixed with 5 l of 4ϫ SDS-sample buffer and boiled for 2 min. The resulting protein samples (5 l) were separated on 12% SDS-polyacrylamide gels with 4% staking gels (BioRad) using standard SDS-PAGE conditions. After electrophoresis, proteins were electrophoretically transferred (Trans-Blot System; Bio-Rad) to Protran BA85 nitro-cellulose membranes (Scheicher & Schuell, Dassel, Germany) using standard methodology. Protein blots were blocked in Trisbuffered saline (TBS) containing 0.1% Tween-20 (TBS-T) and 5% bovine serum albumin (BSA) for 1 h at room temperature. The blots were incubated with B1062 antisera (rabbit primary antibody) at a final dilution of 1:20,000 in TBS-T containing 1% BSA for 2 h at room temperature. After extensive washing in TBS-T, blots were incubated for 1 h at room temperature with secondary antibody (goat anti-rabbit IgG conjugated to horseradish peroxidase; Sigma) at a dilution of 1:10,000 in TBS-T, 1% BSA. Unbound antibodies were removed by washing blots in TBS-T. Specific antigen-antibody complexes were detected using enhanced chemiluminesence (ECL System, Amersham) with exposure times of 30 s to 2 min. Control immunoblot analyses were also performed as described above except that either preimmune serum or antiserum B1062 (at 1:1,000 dilution in PBS) preincubated with 10 g of BEST5-PEP-1 (antigen-blocking peptide) for 16 h at 4°C was used as primary antibody (both at final dilutions of 1:20,000).
Immunohistochemistry
Tissues used for immunolocalization studies were dissected out, dipped in 10% polyvinyl alcohol (PVA, Sigma) and immediately frozen in chilled n-hexane (Ϫ70°C). The tissues were mounted in 10% PVA on brass chucks and 5-7 m sections cut using a Brights cryostat (Brights Instrument Co., Huntington, U.K.). Sections were collected on Vectorbonded slides (Vector Laboratories, Peterborough, U.K.) and stored at Ϫ35°C until use. Prior to immunolocalization, the sections were fixed in 4% paraformaldehyde for 5 min and endogenous peroxidase activity was depleted with 3% hydrogen peroxide (Sigma) for 30 min. A further preincubation was performed with 10% normal goat serum (Vector Laboratories) for 30 min to block nonspecific antibody binding. Sections were incubated with the primary antibody (B1062, rabbit anti-BEST5 at 1:500 dilution) for 30 min, followed by biotinylated goat anti-rabbit secondary antibody (Vector Laboratories; 1:200 dilution) for 10 min and avidin-biotinylatedperoxidase reagent (ABC Elite, Vector Laboratories, 1:50 dilution) for 15 min. Peroxidase activity was visualized with 0.5 mg/ml diaminobenzidine (Sigma) with 0.3% hydrogen peroxide as substrate. All dilutions were made up in phosphate-buffered saline (PBS), pH 7.4 and incubations were performed at room temperature with three PBS washes
Mechanical loading in vivo
The left ulnae of five male Wistar rats (85-88g body weight) were loaded in vivo under general anesthesia essentially as described previously (26) (26) . The unloaded contralateral bones from each animal were used as controls. Loaded and control bone sections were processed for BEST5 immunolocalization as described above.
RESULTS
Molecular cloning of best5 cDNA
Sequence analysis (BLAST and FASTA searches of GeneBank and EMBL databases) of the original 576 bp best5 DD-PCR product indicated that it represented a novel gene. The full-length best5 cDNA was cloned by rapid amplification of cDNA ends (RACE) using best5 RACE1 and RACE2 primers. The best5 RACE2 primer resulted in the amplification of an ϳ300 bp product whereas the best5 RACE1 primer generated a product of ϳ3.3 kb. Both the RACE1 and RACE2 products were cloned into the plasmid pCR 2.1, and four individual clones from each reaction were sequenced. Both RACE products contained the predicted sequence of the original DD-PCR product and confirmed that it was located near the 3Ј end of the best5 cDNA. The complete sequence of the rat best5 cDNA (EMBL/GeneBank accession number Y07704) contains an open reading frame (best5-ORF1) of 1.1 kb located at the 5Ј end of the cDNA. The best5-ORF1, which has the potential to code for a protein of 360 amino acids, is followed by a large 3Ј untranslated region terminating in a heterogeneous poly(A) tail.
BLAST2 search revealed two close homologs of best5: a human homologue cig5 (27) (accession number AF026941) (Eϭe Ϫ166 ) and an uncharacterized protein, VIG-1 (accession number AF076620), identified from rainbow trout (Oncorhynchus mykiss; Eϭe Ϫ141 ). The protein sequence analysis performed using the program BESTFIT revealed that all three proteins have very strong homology between their carboxyl-terminal domains. Best5:68 -360 vs. cig5:67-359 shows 91% sequence identity, whereas best5:68 -360 vs. VIG-1:56 -348 has 79% identity. Homology in the amino-terminal domain is much weaker: best5: 1-67 vs. cig5:1-66 shows 44% identity whereas VIG-1:1-55 domain shows no significant homology with either best5 or cig5. Multiple sequence alignment of all three sequences is presented in Fig. 1 . In addition, 20% of the best5 protein shares weak sequence homology to a domain characteristic to a family of mainly prokaryotic proteins involved in the biosynthesis of metallo cofactors.
Expression of best5 mRNA
The expression profile of best5 was investigated by Northern blot analysis of total RNA obtained from various rat tissues. The multiple-tissue Northern blot was probed with the best5-PCR1 probe as described in Materials and Methods and a single band of ϳ4 kb in size was detected as shown in Fig. 2A . This multipletissue Northern blot shows that expression of best5 occurs predominantly in bone marrow and spleen, with none detectable in brain, liver, thymus, and muscle. The best5 mRNA transcript was also evident in lung, heart, cortical bone, and kidney, but at much lower levels of expression than in either bone marrow or spleen.
To clarify the potential role of best5 in bone formation, we examined the profile of its expression in cultures of differentiating primary rat osteoblasts. The primary ROBs can be induced to form large numbers of alkaline phosphatase-positive cells and mineralized nodules in vitro, which is phenotypic of mature osteoblasts. Northern blot analysis of RNA obtained from these cultures at different time points showed a temporal pattern of best5 expression (Fig.  2B) . The best5 mRNA was not detectable during the early stages of culture when the population consists mainly of undifferentiated cells. However, by day 21, when the culture consists of differentiating and mature osteoblasts, which are in the process of depositing matrix that finally becomes mineralized, the expression of best5 is clearly elevated. The expression of best5 then declines to a much reduced level at 35 days in culture when the nodules are fully mineralized.
The kinetics of best5 mRNA induction in MG63 cells by hIFN-␣ and hIFN-␥ were investigated by Northern blot analysis. MG-63 cells were treated with 100 IU/ml of either hIFN-␣, hIFN-␥, or PBS (control) and total RNA was extracted at various time points poststimulation. The expression of best5 mRNA was determined by Northern blot analysis of these RNA samples (Fig. 3) . As shown in Fig. 3 , the kinetics of best5 mRNA induction by the two types of IFNs were distinct. hIFN-␥ induced a continued and prolonged induction of best5 mRNA, which remained elevated 24 h poststimulation. hIFN-␣, however, elicited a transient induction of best5 mRNA, which peaked at 4 h and returned to basal levels 24 h after stimulation. This distinct response to IFN-␣ and IFN-␥ is common among the small subset of interferon-stimulated genes responsive to both types of IFNs with a resulting potentiation of induction in the presence of both IFNs. We also investigated the effects of PTH, IL-1␤, IL-6, IGF-1, Vit. D 3 , and dexamethasone on best5 gene expression in MG63 cells. These agents did not induce any significant change in best5 mRNA levels (data not shown), which highlights the specificity of the IFN-stimulated induction of best5 gene expression.
Immunodetection of BEST5 protein expression
The rabbit polyclonal antiserum B1062 was raised against BEST5-PEP-1 peptide and used in Western blot analysis and immunolocalization studies. Western blot analysis of B1062 antiserum using total cell lysates from primary rat osteoblasts detected a band of 27 kDa. This 27 kDa band was confirmed to contain the BEST5-PEP-1 epitope by Western blot analysis with antiserum B1062 preincubated with 10 g of BEST5-PEP-1 as a blocking peptide. As shown in Fig. 4 , preincubation of antiserum B1062 with BEST5-PEP-1 blocking peptide results in the absence of the 27 kDa band that is present in the blot incubated with B1062 alone. Multiple sequence alignment of the potential coding regions of the rat best5, its human homologue cig5, and the uncharacterized protein VIG-1 from Oncorhynchus mykiss (trout). Sequence identity is marked by an asterisk (*) and increasing similarities by (.) and (:), respectively. Alignment was calculated using the program CLUSTAL W (24), except the 1-55 amino-terminal stretch of the VIG-1 sequence was shifted manually as it does not show any significant homology to either of the other two sequences.
The antiserum B1062 was used in immunolocalization studies to determine the nature of the cells expressing BEST5 protein in neonatal rat tibiae. Figure 5 shows that BEST5 protein was specifically localized to cells of the periosteum and osteoblasts lining forming bone surfaces on both periosteal and endosteal surfaces. In addition, specific localization was also present on articular surfaces of cartilage and in perichondoral cells but was absent in chondrocytes (results not shown). No specific BEST5 protein localization was evident in multi-nucleated osteoclasts, osteocytes, muscle myoblasts, and in the majority of the various stem and hematopoietic cells present in the bone marrow. Serial sections incubated with BEST5-PEP-1 blocked B1062 antiserum served as negative controls and showed little or no specific staining.
Induction of BEST5 by mechanical loading in vivo
In sections from bones loaded in vivo, there was clear induction of a formative response on the medial periosteal surface of the ulna. In control bones, this surface undergoes resorption as a result of the modeling drifts by which the bone acquires its adult shape, and is characterized by a narrow band of cells between the overlying muscle and the bone (26) . Cells on this surface have been shown to express high levels of the enzyme tartrate-resistant acid phosphatase (26) , which is a characteristic of osteoclasts and their precursors. Loaded bones had a much broader band of plump cuboidal osteoblastic cells that expressed high levels of BEST5 (Fig. 6) . The highest levels of expression were seen in the cells most peripheral to the bone surface.
DISCUSSION
The complex intercellular signaling that regulates the function of the cells involved in bone formation and resorption underlies the physiological control of bone mass. The identification of physiological roles in bone for cytokines originally thought to be expressed exclusively in the immune system has been a feature of research in recent years. In these studies, we demonstrate one potential intermediary in the action of interferons as regulators of osteoblast function. Furthermore, the induction of best5 expression by mechanical loading suggests a further link between interferon action and adaptive remodeling.
Although we first identified best5 in differential display studies in order to study the effects of estrogen in bone, estrogen did not regulate the gene in subsequent studies. However, at that stage identification of the human cig5 gene by others (27) , which shares high homology within its coding region with best5, gave us additional clues to the regulation of this gene. Those workers had identified cig5 from virus-stimulated cells and shown regulation by IFN-␣, so it was logical for us to investigate interferon regulation of best5 gene expression in bone cells.
Regulation of best5 gene expression by both Type I (IFN-␣) and Type II (IFN-␥) interferons in the human MG63 cell line increased the likelihood that best5 was involved in the process of bone formation, particularly as the two types of interferon have kinetically different effects. These findings point to IFN-␥ as a major physiological regulator of best5 expression in bone cells in vivo. Other osteotropic factors so far tested (PTH, IL-1␤, IL-6, IGF-1, Vit. D 3 , and dexamethasone) were ineffective in modulating the expression of best5. However, we cannot rule out the possibility that other as yet untested osteotropic factors may share with interferons the ability to modulate best5 expression. It is not clear yet whether the induction of best5 by mechanical loading acts through an interferon-mediated pathway.
The Northern analysis of best5 expression in IFN stimulated MG63 cells (Fig. 3) shows two distinct hybridization bands of 3.9 and 3.2 kb in size whereas the ROB Northern blots revealed only the presence of the predominant 3.9 kb band. A number of reasons could explain this observation. The bands may result from abnormal splicing of the best5 mRNA in this particular human cell line. Alternatively, it is possible that in rat, only the 3.9 kb best5 transcript is expressed whereas human cells express both 3.9 kb and 3.2 kb best5 transcripts. It is worth noting that the cloned human cig5 cDNA is 3.2 kb in size whereas the rat best5 cDNA is 3.9 kb.
The sequence analysis presented in this paper demonstrates that best5 is part of a new family of genes that encompasses cig5 (human) and VIG-1 (trout). All members of this new family of genes have been shown to be expressed in response to either viruses or IFNs, suggesting that the high sequence homologies between the three genes is matched by related functions. Since cig5 was first detected in response to virus infection of human fibroblasts (27) , the high level of best5 expression seen in the bone and spleen tissues could be suggested to be due to latent viral infection of the animals during rearing. However, in primary cultures of neonatal rat osteoblasts, the expression of best5 is not evident during the early stages of culture, as would be expected if the cells were obtained from virally infected animals. Regulated best5 expression is temporal only during the later stages of bone nodule matrix formation and spatial during bone formation in vivo, suggesting that its expression plays an important role in osteoblast function.
Western blot analysis of total cell proteins from primary ROBs using our polyclonal antibody confirmed that the 27 kDa band contains the epitope present within the BEST5-PEP-1 blocking peptide. The predicted molecular mass of the best5 coding region is 42 kDa, which contrasts with the observed BEST5-PEP-1 containing band of 27 kDa. The difference in the predicted molecular mass and the observed 27 kDa band may possibly be due to posttranslational processing of the BEST5 protein. This potential processing event may possibly involve protease cleavage of the BEST5 protein at the carboxylterminal domain (amino acid 1-68), since this is the least conserved region of this new family of proteins (Fig. 1) .
The expression of best5 in osteoblasts both in vivo and in vitro is consistent with the mechanical loading experiments. In that study, a regimen of loading that would subsequently induce formation of mineralized bone by 7 days (26) was (at 5 days) associated with periosteal proliferation and increased levels of best5 expression. Since the equivalent surfaces of the control contralateral bones were undergoing resorption, there was no detectable best5 expression. This provides clear evidence that best5 expression is an early response to stimuli capable of modulating osteoblast proliferation such as mechanical loading and interferons. The main sites of BEST5 protein expression in rat tibiae are consistent with the alterations in phenotype of transgenic mice overexpressing IFN-␥ (18). These mice have osteochondrodysplasia, with abnormal growth/development of both cartilage and bone, and are characterized by complex osteogenesis imperfecta-like lesions, chondrodysplasia, and osteoarthritis, accompanied by reduced cortical bone thickness and increased incidence of fractures. These defects cannot adequately be explained by the known actions of the interferons in bone and joint cells (12, 28 -32) . These observations indicate that the defects observed in the transgenic mice are not solely due to inhibition of osteoclast formation/function and reduced collagen synthesis by osteoblasts. This suggests that IFN-␥ modulates the function of osteoblasts, osteoclasts, and chondrocytes, resulting in defects of both bone and cartilage. Further support for such a hypothesis is demonstrated by the induction of best5 by loading. It would be of interest to determine whether in IFN null mice there was a normal response to loading and/or an induction of best5 expression.
Our studies demonstrate that best5 is a member of a novel family of interferon-stimulated genes that is normally expressed at high levels by actively forming osteoblasts, whether that activity is part of normal growth or induced by an external stimulus such as mechanical loading. The fact that best5 is also induced by IFNs leads to the inference that the mechanism of action of these cytokines in regulating osteoblast differentiation and/or proliferation in-volves best5. If best5 is an intermediary that precedes osteoblastic bone formation, then it could provide a target for clinical manipulation of bone mass.
